AVARIJN2 study

Quality of life in asymptomatic patients with severe aortic stenosis; up to 10-years of follow-up

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

NL-OMON

Registry ID

NL-OMON21621

Enrollment

Registered

2016-05-19

Start date

2016-07-01

Completion date

Unknown

Last updated

2024-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Aortic valve stenosis

Interventions

Retrospective follow-up of the asymptomatic patients in the AVARIJN study

Eligibility

Inclusion criteria

Inclusion criteria: - Adult patients, mentally competent and 18 years of age or older - Inclusion in the AVARIJN study

Exclusion criteria

Exclusion criteria: - Patients who are not able to give informed consent

Design outcomes

Primary

Measure	Time frame
The primary objective is to determine the quality of life assessed with the SF-36V2¢â questionnaire in asymptomatic patients with severe aortic stenosis, the mortality (all-cause and specific cause) as well as the determination of the aortic valve function by an echocardiogram.	—

Secondary

Measure	Time frame
The secondary objective is to depict the emanated complications occurred during follow-up.	—

Contacts

Public ContactA.P. Kappetein

Erasmus MC Rotterdam Dept. Cardio Thoracic Surgery 's Gravendijkwal 230

a.kappetein@erasmusmc.nl+31 10 7032150

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)